Company
BVF Partners
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Superluminal Medicines | Series B | 2026-09-03 | Lead |
| Expedition Therapeutics | Series B | 2026-08-05 | |
| Crossbow Therapeutics | Series B | 2026-03-19 | |
| Expedition Therapeutics | Series A | 2025-10-10 | Lead |
| Antares Therapeutics | Series A | 2025-06-11 | Lead |
| Merida Biosciences | Series A | 2025-04-09 | Lead |
| Ambrosia Biosciences | Series A | 2024-12-11 | |
| Ambrosia Biosciences | Series A Financing | 2024-08-21 | Lead |
| Diagonal Therapeutics | Financing | 2024-04-04 | Lead |
| Lassen Therapeutics | Series B | 2023-12-20 | |
| Forward Therapeutics | Series A Financing | 2023-11-08 | Lead |
| Septerna | Series B Financing | 2023-07-17 | |
| Crossbow Therapeutics | Series A Financing | 2023-07-11 |